---
figid: PMC8862482__10020_2022_453_Sch1_HTML
figtitle: Activation of dopamine receptor D1 promotes osteogenic differentiation and
  reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathway
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC8862482
filename: 10020_2022_453_Sch1_HTML.jpg
figlink: /pmc/articles/PMC8862482/figure/Sch1/
number: SF1
caption: Dexamethasone inhibites osteogenic differentiation and induces bone loss
  by inhibiting the activation of dopamine receptor D1 via downregulating the ERK1/2
  signaling pathway
papertitle: Activation of dopamine receptor D1 promotes osteogenic differentiation
  and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling
  pathway.
reftext: Jie Zhu, et al. Mol Med. 2022;28:23.
year: '2022'
doi: 10.1186/s10020-022-00453-0
journal_title: Molecular Medicine
journal_nlm_ta: Mol Med
publisher_name: BioMed Central
keywords: Glucocorticoid-induced bone loss | D1R | Osteoblast | ERK1/2 | Osteoporosis
automl_pathway: 0.9539843
figid_alias: PMC8862482__SF1
figtype: Supplemental figure
redirect_from: /figures/PMC8862482__SF1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8862482__10020_2022_453_Sch1_HTML.html
  '@type': Dataset
  description: Dexamethasone inhibites osteogenic differentiation and induces bone
    loss by inhibiting the activation of dopamine receptor D1 via downregulating the
    ERK1/2 signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Dopamine
  - D1
  - Dexamethasone
---
